TAC launches Competition Commission complaint against MSD (Merck) for unlawfully refusing to grant licenses to allow for generic production of and affordable access to generic efavirenz.
- Monopolies are causing “artificial rationing” in COVID-19 crisis as 3 biggest global vaccine giants sit on sidelines
- SAVE LIVES NOW: SUPPORT THE COVID-19 TRIPS WAIVER
- Minister Patel must make COVID-19 medicines accessible to all by taking steps to #FixThePatentLaws
- Fix the Patent Laws Coalition supports South Africa and India’s proposal to facilitate access to COVID-19 vaccines
- More than 80 academics, researchers and teachers call on President Ramaphosa to Fix the Patent Laws